TN-401, a Recombinant Adeno-associated Virus Serotype 9 (AAV9) Containing Plakophilin-2 (PKP2) Transgene, in Adults with PKP2 Mutation-associated Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC)

Overview

About this study

The purpose of this study is to evaluate the safety, tolerability, and pharmacodynamics (PD) of TN-401 in adult patients with symptomatic PKP2 mutation-associated ARVC. The trial will consist of 2 escalating dose cohorts. All patients will receive active drug.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

- PKP2 mutation (pathogenic or likely pathogenic)

- Arrhythmogenic Right Ventricular Cardiomyopathy as defined by the 2010 revised Task
Force Criteria

- Left Ventricular Ejection Fraction ≥50%

- Functioning Implantable Cardiac Defibrillator with remote integration capabilities ≥12
months prior to enrollment

- NYHA Functional Class I, II, or III

- Frequent premature ventricular contractions (PVCs)

Exclusion Criteria:

- High AAV9 neutralizing antibody titer

- Prior myocardial infarction

- Right Ventricular Heart Failure

- Class IV Heart Failure

- Clinically significant renal disease

- Clinically significant liver disease

Note: Other protocol defined Inclusion/Exclusion Criteria may apply.

Eligibility last updated 4/2/2024. Questions regarding updates should be directed to the study team contact.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

John Giudicessi, M.D., Ph.D.

Open for enrollment

Contact information:

CVRU Heart Rhythm Services Research Team

(507) 255-0774

More information

Publications

Publications are currently not available